Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05180565 | Safe Anastomosis Feasibility Study(SAFE2019) | completed | N/A | 27 | SafeHeal IncINDUSTRY | 2 | May 1, 2026 | clinicaltrials |
| NCT05004350 | A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.(NAUTICALCRC) | completed | Phase 2 | 107 | Pierre Fabre MedicamentINDUSTRY |
| 1 |
| Apr 30, 2026 |
| clinicaltrials |
| NCT06212128 | RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study(RAPIDO) | completed | — | 57 | Sengkang General HospitalOTHER | 0 | Apr 30, 2026 | clinicaltrials |
| NCT06866678 | Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery | completed | — | 200 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT04558398 | Impact of Exercise on Mitochondria in Cancer Patients.(ICCE-Mito) | completed | N/A | 15 | University of NottinghamOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT02299596 | Physical Activity in Relation to Surgical Procedures | completed | N/A | 761 | Sahlgrenska University HospitalOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06428487 | Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer | completed | Phase 2 | 30 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT00819208 | Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer(CHALLENGE) | completed | N/A | 889 | Canadian Cancer Trials GroupNETWORK | 6 | Apr 24, 2026 | clinicaltrials |
| NCT04868773 | Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy | completed | Phase 1 | 15 | University of California, IrvineOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT01787500 | Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | completed | Phase 1 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03981146 | A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer(ANICCA) | completed | Phase 2 | 35 | University of BirminghamOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05414448 | Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection(AIDEN) | completed | N/A | 1,726 | Chinese University of Hong KongOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT02584985 | Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal Cancer(ETAP) | completed | Phase 3 | 226 | Institut Paoli-CalmettesOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT02437851 | Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection | completed | Phase 2 | 16 | AIDS Malignancy ConsortiumNETWORK | 1 | Apr 20, 2026 | clinicaltrials |
| NCT03965325 | FOcUs on Colorectal CAncer oUtcomes: Long-Term Study(Foucault) | completed | — | 133 | IHU StrasbourgOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05195970 | Walnuts and Colon Health | completed | N/A | 140 | UConn HealthOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT02110329 | Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study(Code Barre) | completed | N/A | 401 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT02557061 | Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers(TIL) | completed | N/A | 56 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT02872779 | Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer(COCA-MACS) | completed | N/A | 74 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04355156 | Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer(AXMUS-C) | completed | Phase 2 | 52 | Imperial College LondonOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04610086 | Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study(CyDESA) | completed | — | 846 | Corporacion Parc TauliOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01822444 | ANGIOPREDICT. ICORG 12-16, V3 | completed | — | 76 | Cancer Trials IrelandNETWORK | 2 | Apr 13, 2026 | clinicaltrials |
| NCT03699111 | Identification of New Patient Stratification Tools in MSS RAS mt mCRC(COLOSSUS) | completed | — | 29 | Cancer Trials IrelandNETWORK | 3 | Apr 13, 2026 | clinicaltrials |
| NCT04544852 | Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer | completed | N/A | 60 | National University Health System, SingaporeOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05461430 | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)(TraveraRTGx) | completed | — | 72 | Travera IncINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07526090 | Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong | completed | — | 500 | Qianfoshan HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | completed | Phase 2 | 58 | Canadian Cancer Trials GroupNETWORK | 2 | Apr 9, 2026 | clinicaltrials |
| NCT06549803 | Comparison of Method for Skin Closure in Colorectal Cancer. | completed | N/A | 304 | Yoon Suk LeeOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT04081779 | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | completed | N/A | 261 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT06973161 | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors | completed | — | 140 | AstraZenecaINDUSTRY | 12 | Apr 8, 2026 | clinicaltrials |
| NCT03550885 | Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk | completed | N/A | 15 | University of Illinois at ChicagoOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07512726 | DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer | completed | N/A | 24 | Ilknur YaziciogluOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT03798626 | Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers | completed | Phase 1 | 167 | Novartis PharmaceuticalsINDUSTRY | 15 | Apr 1, 2026 | clinicaltrials |
| NCT05064410 | Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative | completed | N/A | 188 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05515796 | Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors | completed | Phase 2 | 189 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT02437656 | Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.(METCAP) | completed | Phase 2 | 60 | Centre Oscar LambretOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05039177 | A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies(HERKULES-3) | completed | Phase 1 / Phase 2 | 101 | Erasca, Inc.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06698289 | Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients | completed | — | 70 | Mersin UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06006260 | Changes of Low Anterior Resection Syndrome and Balance Ability in Patients With Rectal Cancer. | completed | — | 107 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06712901 | Social Media and Cancer Screening Information | completed | N/A | 2,030 | University of UtahOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05411133 | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | completed | Phase 1 | 33 | Arbele Pty LtdINDUSTRY | 2 | Mar 19, 2026 | clinicaltrials |
| NCT03292289 | Assessment of Symptoms and Consequences of Coloanal Continuity Reconstruction(QUALIPRO) | completed | N/A | 65 | Centre Oscar LambretOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT02310477 | Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting(REBECCA) | completed | — | 704 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT01904955 | Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort | completed | — | 598 | Centre Hospitalier Universitaire DijonOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT03223779 | Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer | completed | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT02213913 | Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas | completed | Phase 1 / Phase 2 | 55 | University of ChicagoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT03446157 | Palbociclib and Cetuximab in Metastatic Colorectal Cancer | completed | Phase 2 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 1, 2026source: clinicaltrials